ArticleNature communications2025
Integrating protein language and geometric deep learning models for enhanced vaccine antigen prediction.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From sites to structure to serology: a roadmap for structure-aware molecular evolution of antigenically evolving viruses.Journal of virology · 2026Review
- Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus.Virologica Sinica · 2026Review
- ImmUQBench: a benchmark on uncertainty quantification of protein immunogenicity prediction.Oxford open immunology · 2026Article
- Computational identification of B- and T-cell epitopes: a unified task taxonomy and review of databases, datasets, predictive pipelines, and gaps.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccines are the most effective tool in preventing and managing infectious diseases. One of the critical challenges in vaccine development is the selection of suitable target antigens from the thousands of proteins produced by pathogens. Artificial intelligence is anticipated to play a significant role in addressing this challenge. In this study, we develop a framework termed PLGDL for protective antigen prediction that employs Protein Language and Geometric Deep Learning models. This framework leverages both primary sequence features and three-dimensional structural features of protein antigens, thereby reducing the biases associated with manually curated features. Our integrated model exhibits robustness across both constructed and public datasets and is applicable to viruses, bacteria, and eukaryotic pathogens. Notably, when applied to the ongoing Mpox outbreak, our model not only quickly identifies multiple known antigens but also discovers a protective antigen: G10R. Here, our study provides a high-performance screening tool for protective vaccine antigen prediction by synergistically utilizing the capabilities of protein language and geometric deep learning models, providing substantive insights and methodological advancements for rapid vaccine development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.